ADVFN - Advanced Financial Network.
HOME» NYSE » V » VRX Stock Price » VRX Stock News

Valeant Pharma Share News

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades

Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals

PARIS -(Dow Jones)- French drug company Sanofi-Aventis (SAN.FR) announced Monday the finalization of the sale of its Canadian dermatology business, Dermik, to Valeant Pharmaceuticals International Inc. (VRX) for $422.5 million. In a statement, Sanofi said the transaction includes an aesthetic and therapeutic business in the U.S. and Canada, as well as an aesthetic business around the world. Sanofi's Canadian unit will continue its operations in Greater Montreal, said the company. -By Nadya Masidlover, Dow Jones Newswires; +33 1 4017 1740; nadya.masidlover@dowjones.com

Stock News for Valeant Pharma (VRX)
DateTimeHeadline
07/28/201506:06:27Quarterly Report (10-q)
07/26/201521:52:43Teva Poised to Get a Big Boost in Generics
07/23/201507:30:08Valeant Upgrades Views With Big Quarter
07/23/201506:15:19Current Report Filing (8-k)
07/23/201506:00:00Valeant Pharmaceuticals Reports Second Quarter 2015 Financial...
07/23/201506:00:00Valeant Pharmaceuticals Reports Second Quarter 2015 Financial...
07/22/201516:57:31Statement of Changes in Beneficial Ownership (4)
07/22/201516:53:00Statement of Changes in Beneficial Ownership (4)
07/21/201501:00:00HAEi Global Access Program for RUCONEST® Now Live
07/20/201501:00:00Pharming Announces US$17 Million (€15.6 Million) Straight Debt F...
07/17/201508:00:00Valeant Pharmaceuticals Agrees To Acquire Amoun Pharmaceutical
07/17/201508:00:00Valeant Pharmaceuticals Agrees To Acquire Amoun Pharmaceutical
07/17/201506:59:27Current Report Filing (8-k)
07/14/201518:42:00UNILENS VISION INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL...
07/02/201519:19:22Statement of Changes in Beneficial Ownership (4)
07/02/201519:15:56Statement of Changes in Beneficial Ownership (4)
07/02/201519:12:25Statement of Changes in Beneficial Ownership (4)
07/02/201519:07:34Statement of Changes in Beneficial Ownership (4)
07/02/201518:14:34Statement of Changes in Beneficial Ownership (4)
06/30/201514:19:29Towers Watson: Lower Taxes Not Main Driver of Willis Deal

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad